EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
WATERTOWN, Mass., Oct. 28, 2024 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc. ( NASDAQ: EYPT ) , a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that it has commenced an ...
| Ticker |
Sentiment |
Impact |
|
BR
|
Neutral
|
6 %
|
|
EYPT
|
Somewhat Bullish
|
15 %
|
|
C
|
Neutral
|
6 %
|
